To seek a better understanding of potential interracial differences of cell signaling networks, we tested the hypothesis that different RANK- and c-Met-mediated downstream cell signaling components may predict the survival of prostate cancer patients with different racial backgrounds. The gene discussed is TNFRSF11A; the disease is prostate carcinoma.